πŸ‡ΊπŸ‡Έ FDA
Patent

US 11390606

Pyridazinone compounds and uses thereof

granted A61PA61P21/00

Quick answer

US patent 11390606 (Pyridazinone compounds and uses thereof) held by EDGEWISE THERAPEUTICS, INC. expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EDGEWISE THERAPEUTICS, INC.
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P21/00